Based on the results observed using CLSM, to investigate whether Vpr peptides can induce the release of tumor antigens, we used the membrane antigen EGFR as a representative and evaluated the EGFR level in the cell culture supernatants of HT-29 tumor cells treated with Vpr peptides using an ELISA. This evidence concerns the gene EGFR and neoplasm.